Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mitochondrial ATP-sensitive potassium channel (mitoKATP) containing the Sulfonylurea receptor 2 (SUR2) subunit is a key protein complex located in the inner mitochondrial membrane that plays a vital role in cellular protection (PubMed: 9351448). It is composed of a pore-forming inward rectifier potassium channel (Kir) and a regulatory subunit, SUR2, which is a member of the ATP-binding cassette (ABC) transporter family encoded by the ABCC9 gene (UniProt: O60706). The channel acts as a metabolic sensor, opening in response to a decrease in the ATP/ADP ratio or pharmacological triggers, which allows potassium ions to enter the mitochondrial matrix. This influx results in a slight depolarization of the mitochondrial membrane, which helps regulate the production of reactive oxygen species (ROS) and prevents the accumulation of calcium, thereby protecting the mitochondria from damage during stress (PubMed: 15133057). This mechanism is particularly important in the heart, where mitoKATP activation is a primary mediator of ischemic preconditioning, a process that significantly reduces tissue damage during a heart attack. Drugs such as diazoxide and nicorandil target this channel to provide cardioprotective effects, while inhibitors like 5-hydroxydecanoate are used in research to block these protective pathways (StatPearls: NBK557852). Understanding the specific role of the SUR2 subunit in the mitochondrial context is essential for developing therapies that can selectively protect the myocardium without causing systemic side effects like hypotension (PubMed: 10449331).
Activation (opening) of the channel allows potassium influx into the mitochondrial matrix, leading to mild depolarization, reduced ROS generation, and prevention of mitochondrial permeability transition pore (mPTP) opening.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ATP-sensitive potassium channel (mitoKATP) containing Sulfonylurea receptor 2 (SUR2) subunit (mitoKATP (SUR2)).